AI can now flag where patients are getting stuck — from enrollment delays to dropped calls — while also enabling new, compliant ways to analyze these interactions at scale. But surfacing the issue is just the first step. The post Pharma Is Reclaiming Control Over Patient Experience. What Does It Mean For The Hub Model?…
A new survey from Mercer found that 51% of large employers said they are likely or very likely to make health benefit changes that would shift more costs to employees. The post Employers Will Likely Reduce Health Benefits in 2026, New Mercer Survey Reveals appeared first on MedCity News.
The mandatory model will hold hospitals financially accountable for joint replacement episodes from the day of surgery through 90 days post-discharge.
Ellipsis Health has come a long way from its roots in detecting depression via vocal biomarkers. Sage, its charming voice AI agent, is now helping health plans and care management companies directly interact with patients and members, helping them with medication reminders, program recruitment, postop follow up and much more. I spoke with two of…
Maria Sanchez immigrated to the Chicago area from Mexico about 30 years ago. Now 87, she’s still living in the U.S. without authorization. Like many longtime immigrants, she has worked — and paid taxes, including Medicare taxes — all that time. But Sanchez never had health insurance, and when she turned 65, she couldn’t enroll…
The Business Group on Health is paying attention to Medicaid cuts, tariffs, threats to ERISA and more. The post The Policy Trends the Business Group on Health Is Watching appeared first on MedCity News.
Martin Kulldorff, chair of the Trump administration’s reconstituted CDC vaccine panel, made a shocking — and misleading — statement as the group met in September. Referring to a clinical trial, Kulldorff, a biostatistician and former professor at Harvard Medical School, said eight babies born to women who received Pfizer’s covid vaccine while pregnant had birth…
The six new drugs awarded FDA Commissioner’s National Priority Vouchers brings to 15 the total number of therapies selected for the new pilot program. Under this program, the FDA says the standard 10- to 12-month review time could be shaved down to “within months.” The post FDA Adds 6 More Meds to Pilot Program for…
Sidewinder Therapeutics and Stipple Bio each raised mega-rounds of financing to support their approaches to improving the targeting abilities of antibody drug conjugates for cancer. Both startups are on track to enter the clinic next year. The post Two New Takes on Making a Type of Targeted Cancer Therapy Even Better appeared first on MedCity…
Hundreds of foreign doctors about to complete training in the U.S. will have to leave the country if the federal government doesn’t rapidly process their visa waiver applications, which have been languishing since the fall and winter, immigration attorneys say. The waiver program, run by the Department of Health and Human Services, allows physicians who…